SAVA Stock: Cassava Sciences Flies on Fast Track Designation
Cassava Sciences Inc (NASDAQ: SAVA) is rocketing in the market this morning, and for good reason. The company announced the completion of an End-of-Phase 2 meeting with the FDA and will be moving forward with a pivotal Phase 3 study soon. Here’s what’s going on: Skip to What You Want to Read Cassava Sciences Gains … Read more